{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:56:51Z","timestamp":1790312211820,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.nbd.2014.11.007","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T14:43:07Z","timestamp":1416235387000},"page":"89-101","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":105,"special_numbering":"C","title":["Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils"],"prefix":"10.1016","volume":"74","author":[{"given":"Mustafa T.","family":"Ardah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina E.","family":"Paleologou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohua","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sindhu A.","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salema B.","family":"Abul Khair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-Hong","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bared","family":"Safieh-Garabedian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulmonem A.","family":"Al-Hayani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Eliezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M.A.","family":"El-Agnaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2014.11.007_bb0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3389\/fnagi.2014.00197","article-title":"Structure activity relationship of phenolic acid inhibitors of \u03b1-synuclein fibril formation and toxicity","volume":"6","author":"Ardah","year":"2014","journal-title":"Front. Aging Neurosci."},{"issue":"11","key":"10.1016\/j.nbd.2014.11.007_bb0010","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0006-2952(99)00212-9","article-title":"Ginseng pharmacology: multiple constituents and multiple actions","volume":"58","author":"Attele","year":"1999","journal-title":"Biochem. Pharmacol."},{"issue":"4","key":"10.1016\/j.nbd.2014.11.007_bb0015","first-page":"879","article-title":"Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies","volume":"152","author":"Baba","year":"1998","journal-title":"Am. J. Pathol."},{"issue":"4","key":"10.1016\/j.nbd.2014.11.007_bb0020","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0022-2836(03)00520-5","article-title":"A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins","volume":"329","author":"Bussell","year":"2003","journal-title":"J. Mol. Biol."},{"issue":"8","key":"10.1016\/j.nbd.2014.11.007_bb0025","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.febslet.2011.03.046","article-title":"Inhibition and disaggregation of \u03b1-synuclein oligomers by natural polyphenolic compounds","volume":"585","author":"Caruana","year":"2011","journal-title":"FEBS Lett."},{"issue":"8","key":"10.1016\/j.nbd.2014.11.007_bb0030","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1096\/fj.05-5530fje","article-title":"Reductions in levels of the Alzheimer's amyloid beta peptide after oral administration of ginsenosides","volume":"20","author":"Chen","year":"2006","journal-title":"FASEB J."},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0035","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/aps.2008.6","article-title":"Effect of sugar positions in ginsenosides and their inhibitory potency on Na+\/K+\u2013ATPase activity","volume":"30","author":"Chen","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"issue":"4","key":"10.1016\/j.nbd.2014.11.007_bb0040","doi-asserted-by":"crossref","first-page":"342","DOI":"10.5142\/jgr.2012.36.4.342","article-title":"Effects of Panax ginseng in neurodegenerative diseases","volume":"36","author":"Cho","year":"2012","journal-title":"J. Ginseng Res."},{"issue":"2","key":"10.1016\/j.nbd.2014.11.007_bb0045","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1073\/pnas.97.2.571","article-title":"Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy","volume":"97","author":"Conway","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.nbd.2014.11.007_bb0050","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1074\/jbc.M413024200","article-title":"Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species","volume":"280","author":"Dedmon","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"20","key":"10.1016\/j.nbd.2014.11.007_bb0055","doi-asserted-by":"crossref","first-page":"14941","DOI":"10.1074\/jbc.M109.080390","article-title":"Entacapone and tolcapone, two catechol O-methyltransferase inhibitors, block fibril formation of alpha-synuclein and beta-amyloid and protect against amyloid-induced toxicity","volume":"285","author":"Di Giovanni","year":"2010","journal-title":"J. Biol. Chem."},{"issue":"9","key":"10.1016\/j.nbd.2014.11.007_bb0065","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/S1474-4422(03)00501-5","article-title":"The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?","volume":"2","author":"Di Monte","year":"2003","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.nbd.2014.11.007_bb0070","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1212\/01.wnl.0000247740.47667.03","article-title":"Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030","volume":"68","author":"Dorsey","year":"2007","journal-title":"Neurology"},{"issue":"1\u20132","key":"10.1016\/j.nbd.2014.11.007_bb0075","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-5793(98)01418-5","article-title":"Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments","volume":"440","author":"El-Agnaf","year":"1998","journal-title":"FEBS Lett."},{"key":"10.1016\/j.nbd.2014.11.007_bb0080","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(03)00481-2","article-title":"Soluble oligomers for the diagnosis of neurodegenerative diseases","volume":"2","author":"El-Agnaf","year":"2003","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2014.11.007_bb0085","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1006\/jmbi.2001.4538","article-title":"Conformational properties of alpha-synuclein in its free and lipid-associated states","volume":"307","author":"Eliezer","year":"2001","journal-title":"J. Mol. Biol."},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0090","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0925-4439(00)00034-X","article-title":"Approaches to discovery and characterization of inhibitors of amyloid beta-peptide polymerization","volume":"1502","author":"Findeis","year":"2000","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.nbd.2014.11.007_bb0095","first-page":"313","article-title":"Pathobiology of the Lewy body","volume":"80","author":"Galvin","year":"1999","journal-title":"Adv. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0100","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrneurol.2012.242","article-title":"100years of Lewy pathology","volume":"9","author":"Goedert","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12154-009-0027-5","article-title":"Binding mode of Thioflavin T and other molecular probes in the context of amyloid fibrils \u2014 current status","volume":"3","author":"Groenning","year":"2010","journal-title":"J. Chem. Biol."},{"key":"10.1016\/j.nbd.2014.11.007_bb0110","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.biochem.66.1.385","article-title":"Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins","volume":"66","author":"Harper","year":"1997","journal-title":"Annu. Rev. Biochem."},{"issue":"28","key":"10.1016\/j.nbd.2014.11.007_bb0115","doi-asserted-by":"crossref","first-page":"8972","DOI":"10.1021\/bi9904149","article-title":"Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease","volume":"38","author":"Harper","year":"1999","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.nbd.2014.11.007_bb0120","doi-asserted-by":"crossref","first-page":"e58181","DOI":"10.1371\/journal.pone.0058181","article-title":"Chronic administration of anti-stroke herbal medicine TongLuoJiuNao reduces amyloidogenic processing of amyloid precursor protein in a mouse model of Alzheimer's disease","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"10.1016\/j.nbd.2014.11.007_bb0125","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1038\/aps.2013.100","article-title":"Yin and Yang of ginseng pharmacology: ginsenosides vs gintonin","volume":"34","author":"Im","year":"2013","journal-title":"Acta Pharmacol. Sin."},{"issue":"49","key":"10.1016\/j.nbd.2014.11.007_bb0130","doi-asserted-by":"crossref","first-page":"12345","DOI":"10.1021\/bi00164a008","article-title":"Amyloid fibril formation requires a chemically discriminating nucleation event: studies of an amyloidogenic sequence from the bacterial protein OsmB","volume":"31","author":"Jarrett","year":"1992","journal-title":"Biochemistry"},{"issue":"6","key":"10.1016\/j.nbd.2014.11.007_bb0135","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/0092-8674(93)90635-4","article-title":"Seeding \u201cone-dimensional crystallization\u201d of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?","volume":"73","author":"Jarrett","year":"1993","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0145","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.brainres.2006.12.047","article-title":"Neuroprotective effects of ginsenoside Rg3 against homocysteine-induced excitotoxicity in rat hippocampus","volume":"1136","author":"Kim","year":"2007","journal-title":"Brain Res."},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0140","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5142\/jgr.2013.37.8","article-title":"A comprehensive review of the therapeutic and pharmacological effects of ginseng and ginsenosides in central nervous system","volume":"37","author":"Kim","year":"2013","journal-title":"J. Ginseng. Res."},{"issue":"9","key":"10.1016\/j.nbd.2014.11.007_bb0150","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1021\/jf026228i","article-title":"In vitro study of the relationship between the structure of ginsenoside and its antioxidative or prooxidative activity in free radical induced hemolysis of human erythrocytes","volume":"51","author":"Liu","year":"2003","journal-title":"J. Agric. Food Chem."},{"issue":"3","key":"10.1016\/j.nbd.2014.11.007_bb0160","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2174\/157016109788340767","article-title":"Ginseng compounds: an update on their molecular mechanisms and medical applications","volume":"7","author":"L\u00fc","year":"2009","journal-title":"Curr. Vasc. Pharmacol."},{"issue":"6109","key":"10.1016\/j.nbd.2014.11.007_bb0155","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1126\/science.1227157","article-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","volume":"338","author":"Luk","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.nbd.2014.11.007_bb0165","doi-asserted-by":"crossref","first-page":"25","DOI":"10.3389\/fphar.2012.00025","article-title":"Ginsenosides as anticancer agents: in vitro and in vivo activities, structure\u2013activity relationships, and molecular mechanisms of action","volume":"3","author":"Nag","year":"2012","journal-title":"Front. Pharmacol."},{"issue":"Suppl. 3","key":"10.1016\/j.nbd.2014.11.007_bb0170","doi-asserted-by":"crossref","first-page":"S548","DOI":"10.1002\/mds.22062","article-title":"Functional organization of the basal ganglia: therapeutic implications for Parkinson's disease","volume":"23","author":"Obeso","year":"2008","journal-title":"Mov. Disord."},{"issue":"12","key":"10.1016\/j.nbd.2014.11.007_bb0175","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1016\/j.bpj.2012.04.050","article-title":"Fibrillar \u03b1-synuclein and huntingtin exon 1 assemblies are toxic to the cells","volume":"102","author":"Pieri","year":"2012","journal-title":"Biophys. J."},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0003-9861(02)00398-3","article-title":"Structure\u2013function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia (THP-1) cell line","volume":"406","author":"Popovich","year":"2002","journal-title":"Arch. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0185","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1747-0285.2005.00318.x","article-title":"Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism","volume":"67","author":"Porat","year":"2006","journal-title":"Chem. Biol. Drug Des."},{"issue":"7","key":"10.1016\/j.nbd.2014.11.007_bb0190","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.bcp.2010.06.023","article-title":"American ginseng: potential structure\u2013function relationship in cancer chemoprevention","volume":"80","author":"Qi","year":"2010","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.nbd.2014.11.007_bb0195","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1179\/174313209X385572","article-title":"Protective effect of ginsenoside Rb1 on beta-amyloid protein(1\u201342)-induced neurotoxicity in cortical neurons","volume":"31","author":"Qian","year":"2009","journal-title":"Neurol. Res."},{"issue":"6","key":"10.1016\/j.nbd.2014.11.007_bb0200","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/j.1755-5949.2010.00208.x","article-title":"Ginsenosides and their CNS targets","volume":"17","author":"Radad","year":"2011","journal-title":"CNS Neurosci. Ther."},{"issue":"48","key":"10.1016\/j.nbd.2014.11.007_bb0205","doi-asserted-by":"crossref","first-page":"19366","DOI":"10.1021\/ja2029848","article-title":"Mechanism of membrane interaction and disruption by \u03b1-synuclein","volume":"133","author":"Reynolds","year":"2011","journal-title":"J. Am. Chem. Soc."},{"issue":"3","key":"10.1016\/j.nbd.2014.11.007_bb0210","doi-asserted-by":"crossref","first-page":"977","DOI":"10.3233\/JAD-2010-1296","article-title":"Ginsenoside Rg1 attenuates amyloid-beta content, regulates PKA\/CREB activity, and improves cognitive performance in SAMP8 mice","volume":"19","author":"Shi","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"6645","key":"10.1016\/j.nbd.2014.11.007_bb0220","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/42166","article-title":"Alpha-synuclein in Lewy bodies","volume":"388","author":"Spillantini","year":"1997","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.nbd.2014.11.007_bb0215","doi-asserted-by":"crossref","first-page":"6469","DOI":"10.1073\/pnas.95.11.6469","article-title":"Alpha-synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with Lewy bodies","volume":"95","author":"Spillantini","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0225","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.intimp.2005.07.003","article-title":"Structure and biological activity of protopanaxatriol-type saponins from the roots of Panax notoginseng","volume":"6","author":"Sun","year":"2006","journal-title":"Int. Immunopharmacol."},{"issue":"5","key":"10.1016\/j.nbd.2014.11.007_bb0230","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/sj.npp.1300388","article-title":"Abeta(25\u201335)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, a metabolite of protopanaxadiol-type saponins","volume":"29","author":"Tohda","year":"2004","journal-title":"Neuropsychopharmacology"},{"issue":"47","key":"10.1016\/j.nbd.2014.11.007_bb0235","doi-asserted-by":"crossref","first-page":"43495","DOI":"10.1074\/jbc.C100551200","article-title":"Stabilization of partially folded conformation during alpha-synuclein oligomerization in both purified and cytosolic preparations","volume":"276","author":"Uversky","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0240","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","article-title":"Exogenous \u03b1-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death","volume":"72","author":"Volpicelli-Daley","year":"2011","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.nbd.2014.11.007_bb0245","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neulet.2010.09.076","article-title":"Anti-neuroinflammation effect of ginsenoside Rbl in a rat model of Alzheimer disease","volume":"487","author":"Wang","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.nbd.2014.11.007_bb0250","series-title":"Biological Activities of Ginseng and its Application to Human Health","author":"Wee","year":"2011"},{"issue":"43","key":"10.1016\/j.nbd.2014.11.007_bb0255","doi-asserted-by":"crossref","first-page":"13709","DOI":"10.1021\/bi961799n","article-title":"NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded","volume":"35","author":"Weinreb","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.nbd.2014.11.007_bb0265","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1073\/pnas.1100976108","article-title":"In vivo demonstration that alpha-synuclein oligomers are toxic","volume":"108","author":"Winner","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.nbd.2014.11.007_bb0275","first-page":"828","article-title":"Ginsenoside Rb1 attenuates beta-amyloid peptide(25\u201335)-induced hyperphosphorylation of tau protein through CDK5 signal pathway","volume":"42","author":"Xie","year":"2007","journal-title":"Yao Xue Xue Bao"},{"issue":"4","key":"10.1016\/j.nbd.2014.11.007_bb0270","first-page":"635","article-title":"Ginsenoside Rb1 protects PC12 cells against \u03b2-amyloid-induced cell injury","volume":"3","author":"Xie","year":"2010","journal-title":"Mol. Med. Rep."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114003453?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996114003453?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,17]],"date-time":"2019-08-17T09:53:00Z","timestamp":1566035580000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996114003453"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":53,"alternative-id":["S0969996114003453"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2014.11.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725260287.793502258","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2014.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}